Oral Mucositis (OM) is the most common, debilitating complication of cancer chemotherapy and radiotherapy. It is characterized by inflammation and ulceration in the oral cavity caused by the chemotherapeutic drug substances and radiotherapy used in cancer treatment. It can lead to several problems, including pain, nutritional problems as a result of inability to eat, and increased risk of infection due to open sores in the mucosa. It has a significant effect on the patient’s quality of life and can be dose-limiting (i.e., requiring a reduction in subsequent chemotherapy doses).
The symptoms appear five to ten days after the chemotherapy treatment or 14 days after the start of radiotherapy. The early symptoms include erythema and light discoloration of the mucosa. As OM progresses, erosive lesions and ulcers are developed. Mouth sores are extremely painful and are typically the most distressing manifestation.
Get FREE sample copy at:
The Oral Mucositis market report also covers emerging drugs, current treatment practices, Oral Mucositis market share of the individual therapies, current and forecasted Oral Mucositis Market Size from 2017 to 2030 segmented by seven major markets. The report provides a detailed current Oral Mucositis treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Oral Mucositis Market Key Facts
The incidence of Grade I and II OM has been observed to be higher in comparison to Grade III-IV cases across all the major markets
In 2017, the incident population of Oral Mucositis in the United States was 1,956,351, which as per DelveInsight’s estimates, might increase in 2030.
Key Benefits of Oral Mucositis Market Report
Oral Mucositis market report provides an in-depth analysis of Oral Mucositis Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
The Oral Mucositis market report will help in developing business strategies by understanding the Oral Mucositis Market trends & developments, key players and future market competition that will shape and drive the Oral Mucositis market in the upcoming years.
The Oral Mucositis market report covers Oral Mucositis current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
The report provides a detailed assessment of the Oral Mucositis market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Oral Mucositis is a complication of aggressive chemotherapy and radiotherapy treatments in Head and neck and other cancers. Severe form of OM causes odynophagia or dysphagia leading to difficulty in eating/swallowing and can increase the cost of total cancer therapy.
As per DelveInsight estimates, in 2017, the US had the maximum number of incident cases out of the total incident cases across 7MM followed by Japan. Owing to the changes in the cancer treatment landscape and advancements in technology the rate of increase of incident cases in the United States is expected to come down marginally by 2030. However, the United States is still forecasted to have the maximum cases of OM by 2030. The Oral Mucositis market size is expected to grow during the forecast period owing to the launch of upcoming therapies.
The Oral Mucositis market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Oral Mucositis market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Oral Mucositis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Oral Mucositis Epidemiology
The Oral Mucositis epidemiology section covers insights about historical and current Oral Mucositis patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Oral Mucositis Drugs Uptake and Key Market Players
The Oral Mucositis Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Oral Mucositis market or expected to get launched in the market during the study period. The analysis covers Oral Mucositis market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Since, there is no cure or preventive major available for the condition, to counter such unmet needs many companies are working robustly with focus on novel mechanisms to treat OM. Some of the key players in the Oral Mucositis market includes:
Link Health Pharma
And many others.
And many others.
Table of Content
1. Key Insights
2. Executive Summary
3. Oral Mucositis Competitive Intelligence Analysis
4. Oral Mucositis Market Overview at a Glance
5. Oral Mucositis Disease Background and Overview
6. Oral Mucositis Patient Journey
7. Oral Mucositis Epidemiology and Patient Population
8. Oral Mucositis Treatment Algorithm, Current Treatment, and Medical Practices
9. Oral Mucositis Unmet Needs
10. Key Endpoints of Oral Mucositis Treatment
11. Oral Mucositis Marketed Products
12. Oral Mucositis Emerging Therapies
13. Oral Mucositis Seven Major Market Analysis
14. Attribute Analysis
15. Oral Mucositis Market Outlook (7 major markets)
16. Oral Mucositis Access and Reimbursement Overview
17. KOL Views on the Oral Mucositis Market.
18. Oral Mucositis Market Drivers
19. Oral Mucositis Market Barriers
21. DelveInsight Capabilities
DelveInsight’s Oral Mucositis – Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Oral Mucositis in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Oral Mucositis Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Oral Mucositis market.
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Address:304 S. Jones Blvd #2432
State: New York
Country: United States